Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

419 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Hemorrhagic complications during warfarin treatment].
Gumulec J, Kessler P, Penka M, Klodová D, Králová S, Brejcha M, Wróbel M, Sumná E, Blatný J, Klaricová K, Riedlová P, Lasota Z. Gumulec J, et al. Among authors: wrobel m. Vnitr Lek. 2006 Mar;52 Suppl 1:79-91. Vnitr Lek. 2006. PMID: 16637455 Review. Czech.
[Heparin induced thrombocytopenia].
Králová S, Klodová D, Gumulec J, Novotný J, Klaricová K, Wróbel M, Brejcha M, Sumná E. Králová S, et al. Among authors: wrobel m. Vnitr Lek. 2006 Mar;52 Suppl 1:98-106. Vnitr Lek. 2006. PMID: 16637457 Review. Czech.
10 years of experience with thalidomide in multiple myeloma patients: report of the Czech Myeloma Group.
Minarik J, Sandecka V, Maisnar V, Gregora E, Spicka I, Starostka D, Plonkova H, Jarkovsky J, Walterova L, Wrobel M, Adamova D, Pika T, Melicharova H, Pour L, Radocha J, Pavlicek P, Straub J, Gumulec J, Bacovsky J, Adam Z, Scudla V, Hajek R. Minarik J, et al. Among authors: wrobel m. Leuk Res. 2013 Sep;37(9):1063-9. doi: 10.1016/j.leukres.2013.06.019. Epub 2013 Jul 8. Leuk Res. 2013. PMID: 23845888
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data.
Sandecká V, Pour L, Špička I, Minařík J, Radocha J, Jelínek T, Heindorfer A, Pavlíček P, Sýkora M, Jungová A, Kessler P, Wróbel M, Starostka D, Ullrychová J, Stejskal L, Štork M, Straub J, Pika T, Brožová L, Ševčíková S, Maisnar V, Hájek R. Sandecká V, et al. Among authors: wrobel m. Eur J Haematol. 2021 Oct;107(4):466-474. doi: 10.1111/ejh.13683. Epub 2021 Jul 28. Eur J Haematol. 2021. PMID: 34272773
Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy.
Minarik J, Pavlicek P, Pour L, Pika T, Maisnar V, Spicka I, Jarkovsky J, Krejci M, Bacovsky J, Radocha J, Straub J, Kessler P, Wrobel M, Walterova L, Sykora M, Obernauerova J, Brozova L, Gregora E, Adamova D, Gumulec J, Adam Z, Scudla V, Hajek R; Czech Myeloma Group. Minarik J, et al. Among authors: wrobel m. PLoS One. 2015 Apr 14;10(4):e0123866. doi: 10.1371/journal.pone.0123866. eCollection 2015. PLoS One. 2015. PMID: 25875484 Free PMC article.
A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.
Sandecká V, Hájek R, Pour L, Špička I, Ščudla V, Gregora E, Radocha J, Walterová L, Kessler P, Zahradová L, Adamová D, Valentova K, Vonke I, Obernauerová J, Starostka D, Wróbel M, Brožová L, Jarkovský J, Mikulášová A, Říhová L, Ševčíková S, Straub J, Minařík J, Adam Z, Krejčí M, Král Z, Maisnar V; Czech Myeloma Group. Sandecká V, et al. Among authors: wrobel m. Eur J Haematol. 2017 Jul;99(1):80-90. doi: 10.1111/ejh.12894. Epub 2017 May 11. Eur J Haematol. 2017. PMID: 28384387
419 results